Variations in the vascular endothelial growth factor pathway predict pulmonary complications

Annals of Thoracic Surgery

Volumn 94, Issue 4, 2012, Pages 1079-1085

  Kim, Jae Y ^a   Hildebrandt, Michelle A T ^b   Pu, Xia ^b   Ye, Yuanqing ^b   Correa, Arlene M ^b   Vaporciyan, Ara A ^b   Wu, Xifeng ^b   Roth, Jack A ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NRAS PROTEIN; PROTEIN; RAF PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 3;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ATELECTASIS; BRONCHOPLEURAL FISTULA; CONFERENCE PAPER; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; LOBECTOMY; LUNG CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ASPIRATION; RESPIRATORY ARREST; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE LUNG INJURY; AGED; BIOLOGICAL MARKERS; DNA; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; PNEUMONECTOMY; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; UNITED STATES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866654156     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.05.048     Document Type: Conference Paper

References (29)

1. E.A. Graham Successful removal of an entire lung for carcinoma of the bronchus JAMA 101 1933 1371 1374
2. M.K. Ferguson, A.G. Lehman, C.T. Bolliger, A. Brunelli The role of diffusing capacity and exercise tests Thorac Surg Clin 18 2008 9 17 v
3. M.K. Ferguson, L.B. Reeder, R. Mick Optimizing selection of patients for major lung resection J Thorac Cardiovasc Surg 109 1995 275 281 discussion 281-3
4. M.K. Ferguson, W.T. Vigneswaran Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease Ann Thorac Surg 85 2008 1158 1164 discussion 1164-5
5. A.A. Vaporciyan, K.W. Merriman, F. Ece Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation Ann Thorac Surg 73 2002 420 425 discussion 425-6
6. B.A. Whitson, S.S. Groth, S.J. Duval, S.J. Swanson, M.A. Maddaus Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy Ann Thorac Surg 86 2008 2008 2016 discussion 2016-8
7. M. Gaudino, A. Di Castelnuovo, R. Zamparelli Genetic control of postoperative systemic inflammatory reaction and pulmonary and renal complications after coronary artery surgery J Thorac Cardiovasc Surg 126 2003 1107 1112
8. J.M. Lee, A.C. Lo, S.Y. Yang, H.S. Tsau, R.J. Chen, Y.C. Lee Association of angiotensin-converting enzyme insertion/deletion polymorphism with serum level and development of pulmonary complications following esophagectomy Ann Surg 241 2005 659 665
9. A.D. Shaw, A.A. Vaporciyan, X. Wu, T.M. King Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection Ann Thorac Surg 79 2005 1704 1710
10. R.A. Cox, A.S. Burke, D.L. Traber, D.N. Herndon, H.K. Hawkins Production of pro-inflammatory polypeptides by airway mucous glands and its potential significance Pulm Pharmacol Ther 20 2007 172 177
11. A.R. Medford, N.B. Ibrahim, A.B. Millar Vascular endothelial growth factor receptor and coreceptor expression in human acute respiratory distress syndrome J Crit Care 24 2009 236 242
12. R. Zhai, M.N. Gong, W. Zhou Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS Thorax 62 2007 718 722
13. T. Lahm, P.R. Crisostomo, T.A. Markel, M. Wang, K.D. Lillemoe, D.R. Meldrum The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury Shock 28 2007 4 14
14. C.G. Lee, B. Ma, S. Takyar Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease Proc Am Thorac Soc 8 2011 512 515
15. A.R. Medford, A.B. Millar Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax 61 2006 621 626
16. R.M. Tuder, M. Chacon, L. Alger Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis J Pathol 195 2001 367 374
17. G.L. Walsh, R.C. Morice, J.B. Putnam Jr Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption Ann Thorac Surg 58 1994 704 710 discussion 711
18. M. Shibuya Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1) Int J Biochem Cell Biol 33 2001 409 420
19. P. Lassus, M. Turanlahti, P. Heikkila Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn Am J Respir Crit Care Med 164 10 Pt 1 2001 1981 1987
20. J. Janer, P. Lassus, C. Haglund, K. Paavonen, K. Alitalo, S. Andersson Pulmonary vascular endothelial growth factor-C in development and lung injury in preterm infants Am J Respir Crit Care Med 174 2006 326 330
21. S.H. Reynolds, C.K. Anna, K.C. Brown Activated protooncogenes in human lung tumors from smokers Proc Natl Acad Sci U S A 88 1991 1085 1089
22. E. Kerkhoff, L.M. Fedorov, R. Siefken, A.O. Walter, T. Papadopoulos, U.R. Rapp Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein Cell Growth Differ 11 2000 185 190
23. J.N. Mandrekar Receiver operating characteristic curve in diagnostic test assessment J Thorac Oncol 5 2010 1315 1316
24. A. Barua, S.D. Handagala, L. Socci Accuracy of two scoring systems for risk stratification in thoracic surgery Interact Cardiovasc Thorac Surg 14 2012 556 559
25. J.R. Roberts, G.D. Perkins, T. Fujisawa Vascular endothelial growth factor promotes physical wound repair and is anti-apoptotic in primary distal lung epithelial and A549 cells Crit Care Med 35 2007 2164 2170
26. N.F. Voelkel, R.M. Tuder Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest 106 2000 733 738
27. C.G. Lee, H. Link, P. Baluk Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung Nat Med 10 2004 1095 1103
28. Y. Abadie, F. Bregeon, L. Papazian Decreased VEGF concentration in lung tissue and vascular injury during ARDS Eur Respir J 25 2005 139 146
29. A.R. Medford, S.I. Godinho, L.J. Keen, J.L. Bidwell, A.B. Millar Relationship between vascular endothelial growth factor + 936 genotype and plasma/epithelial lining fluid vascular endothelial growth factor protein levels in patients with and at risk for ARDS Chest 136 2009 457 464